+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Bioengineering Technology Market Report 2026 - Product Thumbnail Image

Bioengineering Technology Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
Smart Life Sciences Manufacturing Market Report 2026 - Product Thumbnail Image

Smart Life Sciences Manufacturing Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Rare Diseases Market Report 2024-2034 - Product Thumbnail Image

Rare Diseases Market Report 2024-2034

  • Report
  • May 2024
  • 344 Pages
  • Global
From
Biotechnology Services Market Report 2026 - Product Thumbnail Image

Biotechnology Services Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
From
Dermatology Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Dermatology Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 250 Pages
  • Global
From
From
From
From
From
Immunomodulators - Global Strategic Business Report - Product Thumbnail Image

Immunomodulators - Global Strategic Business Report

  • Report
  • July 2026
  • 280 Pages
  • Global
From
From
From
Loading Indicator